CONSIDER BUYING BAC (BANK OF AMERICA)
September 16, 2008
Strategic value of MER outweigh potential loses from MER balance sheet. BAC has traditionally done a good job at integrating acquisitions, but MER is a
Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
Strategic value of MER outweigh potential loses from MER balance sheet. BAC has traditionally done a good job at integrating acquisitions, but MER is a
We believe BCS purchase of Lehman assets in bankruptcy is a coup. This is a major change as it will significantly increase BCS presence in
After the close, Samsung announced $26 cash bid for SNDK. The offer is not contingent on financing. We believe there is a distinct possibility of
Recently, we warned against shorting SNDK and recommended buying SNDK around $13 due to possibility of a buy out. Today Korea’s ETimes reports that Samsung
We have very large gains in AMLN. Consider buying to cover majority, say 90% of the position right here at $20.50 range. Tight stop on
There are over 5% gains in just one day. Our methodology calls for taking partial profits in KG here at $11.64 and in ALO at
KG today made public its $33 cash offer for ALO ( Alpharma ). Normally stock of the acquirer falls, but here KG stock has jumped.
As our readers know, we have been very negative on SNDK and have made money shorting it. Today stock dropped $1.79 following cautious comments by